Last reviewed · How we verify
NCT03176394
Efficacy of BLASTX in Catheter Associated Bacteriuria Versus Standard of Care (SOC)
NA trial testing BLASTX Gel in Urinary Tract Infections in 15 participants. Terminated before completion.
18 October 2019
Quick facts
| Lead sponsor | Next Science TM |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 15 |
| Start date | 24 May 2017 |
| Primary completion | 18 October 2019 |
| Estimated completion | 18 October 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- BLASTX Gel
- McKesson Jelly
Conditions studied
- Urinary Tract Infections — all drugs for Urinary Tract Infections →
Sponsor
Next Science TM — full company profile →
Who can join
18 and older, any sex, with Urinary Tract Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a 2-week, single-site, randomized study in adults requiring short-term (≤ 14 days) catheterization. Subjects will be randomized 1:1 to either the biofilm disrupting gel (BLASTX) or SOC (McKesson Jelly) lubricated catheters. Urine and/or catheter DNA analysis will be obtained at catheter insertion, 2, 5, 7 and 14 days after catheterization.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03176394
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urinary Tract Infections
Currently open trials in the same condition.
- NCT06976125 — Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulat · NA · recruiting
- NCT06808451 — Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture · NA · recruiting
- NCT07186465 — Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis · Phase 4 · recruiting
- NCT07207291 — Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers · Phase 1 · recruiting
- NCT06715306 — Intravenous Versus Oral Treatment of the Main Acute Infections · NA · recruiting
Other Next Science TM trials
Trials by the same sponsor.
- NCT04906642 — Clinical Assessment of Next Science Solution on Gustilo and Anderson Type II and IIIA or IIIB Tibial Fractures · NA · terminated
- NCT06119750 — 4-Day Primary Irritation Patch Test of MIS Solution · NA · completed
- NCT04053946 — Clinical Assessment of Next Science Wound Gels in Healing Below the Knee Amputation Surgical Wound Compared to SOC · NA · withdrawn
- NCT04042857 — Safety and Efficacy of Next Science Gel on Toenail Fungus · NA · recruiting
- NCT03738579 — Evaluating Wound Healing With Next Science Gel & Wash. · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03176394 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Next Science TM
- Last refreshed: 7 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03176394.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing